Cargando…

Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils

The Aβ42 peptide rapidly aggregates to form oligomers, protofibils and fibrils en route to the deposition of amyloid plaques associated with Alzheimer's disease. We show that low temperature and low salt can stabilize disc-shaped oligomers (pentamers) that are significantly more toxic to murine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Mahiuddin, Davis, Judianne, Aucoin, Darryl, Sato, Takeshi, Ahuja, Shivani, Aimoto, Saburo, Elliott, James I., Van Nostrand, William E., Smith, Steven O.
Formato:	Texto
Lenguaje:	English
Publicado:	2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922021/ https://www.ncbi.nlm.nih.gov/pubmed/20383142 http://dx.doi.org/10.1038/nsmb.1799

Ejemplares similares

Capping of Aβ42 Oligomers by Small Molecule Inhibitors
por: Fu, Ziao, et al.
Publicado: (2014)

Amyloid-β Forms Fibrils by Nucleated Conformational Conversion of Oligomers
por: Lee, Jiyong, et al.
Publicado: (2011)

Cerebral vascular amyloid seeds drive amyloid β-protein fibril assembly with a distinct anti-parallel structure
por: Xu, Feng, et al.
Publicado: (2016)

Quantification and targeting of elusive neurotoxic amyloid oligomers
por: Bhatt, Nemil, et al.
Publicado: (2022)

Amyloid Oligomer Neurotoxicity, Calcium Dysregulation, and Lipid Rafts
por: Malchiodi-Albedi, Fiorella, et al.
Publicado: (2011)

An N-terminal antibody promotes the transformation of amyloid fibrils into oligomers and enhances the neurotoxicity of amyloid-beta: the dust-raising effect
por: Liu, Yu-Hui, et al.
Publicado: (2015)

rTg-D: A novel transgenic rat model of cerebral amyloid angiopathy Type-2
por: Davis, Judianne, et al.
Publicado: (2022)

Human cerebral vascular amyloid contains both antiparallel and parallel in-register Aβ40 fibrils
por: Irizarry, Brandon A., et al.
Publicado: (2021)

A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Cataldi, Rodrigo, et al.
Publicado: (2021)

An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?
por: Sciaccaluga, Miriam, et al.
Publicado: (2021)

Nanoscopic insights into the surface conformation of neurotoxic amyloid β oligomers
por: Banchelli, Martina, et al.
Publicado: (2020)

Amyloid β Dodecamer Disrupts the Neuronal Membrane More Strongly than the Mature Fibril: Understanding the Role of Oligomers in Neurotoxicity
por: Nguyen, Hoang Linh, et al.
Publicado: (2022)

Tau Oligomers Neurotoxicity
por: Niewiadomska, Grazyna, et al.
Publicado: (2021)

The neurotoxicity of amyloid β-protein oligomers is reversible in a primary neuron model
por: Tanokashira, Daisuke, et al.
Publicado: (2017)

Publisher Correction: A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Cataldi, Rodrigo, et al.
Publicado: (2021)

Lysosomal Enzyme Glucocerebrosidase Protects against Aβ(1-42) Oligomer-Induced Neurotoxicity
por: Choi, Seulah, et al.
Publicado: (2015)

Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin
por: Shin, Thuzar M, et al.
Publicado: (2008)

Toxic species in amyloid disorders: Oligomers or mature fibrils
por: Verma, Meenakshi, et al.
Publicado: (2015)

Identification of on- and off-pathway oligomers in amyloid fibril formation
por: Dear, Alexander J., et al.
Publicado: (2020)

Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers
por: Novo, Mercedes, et al.
Publicado: (2018)

Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β(1-42)
por: Bate, Clive, et al.
Publicado: (2004)

RRY Inhibits Amyloid-β(1–42) Peptide Aggregation and Neurotoxicity
por: Sun, Xicui, et al.
Publicado: (2021)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
por: Izzo, Nicholas J., et al.
Publicado: (2014)

Rapid Conversion of Amyloid-Beta 1-40 Oligomers to Mature Fibrils through a Self-Catalytic Bimolecular Process
por: Morel, Bertrand, et al.
Publicado: (2021)

Origin of metastable oligomers and their effects on amyloid fibril self-assembly
por: Hasecke, Filip, et al.
Publicado: (2018)

Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils
por: Muschol, Martin, et al.
Publicado: (2023)

Oligomer Formation by Amyloid-β42 in a Membrane-Mimicking Environment in Alzheimer’s Disease
por: Rosenberry, Terrone L., et al.
Publicado: (2022)

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts
por: Sandberg, Anders, et al.
Publicado: (2022)

Amphiphilic stilbene derivatives attenuate the neurotoxicity of soluble Aβ(42) oligomers by controlling their interactions with cell membranes
por: Yu, Zhengxin, et al.
Publicado: (2022)

The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?
por: Broersen, Kerensa, et al.
Publicado: (2010)

An N-terminal Fragment of the Prion Protein Binds to Amyloid-β Oligomers and Inhibits Their Neurotoxicity in Vivo
por: Fluharty, Brian R., et al.
Publicado: (2013)

Role of Electrostatic Interactions in Calcitonin Prefibrillar Oligomer-Induced Amyloid Neurotoxicity and Protective Effect of Neuraminidase
por: Cariati, Ida, et al.
Publicado: (2021)

Brain Hydrophobic Peptides Antagonists of Neurotoxic Amyloid β Peptide Monomers/Oligomers–Protein Interactions
por: Gutierrez-Merino, Carlos
Publicado: (2023)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
por: Garai, Kanchan, et al.
Publicado: (2014)

Liquid–liquid phase separation of amyloid-β oligomers modulates amyloid fibrils formation
por: Gui, Xinrui, et al.
Publicado: (2023)

Reversibility of Aβ oligomer neurotoxicity
por: Araki, Wataru
Publicado: (2017)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
por: Izzo, Nicholas J., et al.
Publicado: (2014)

Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers
por: Kayed, Rakez, et al.
Publicado: (2007)

Beta‐amyloid 1‐42 monomers, but not oligomers, produce PHF‐like conformation of Tau protein
por: Manassero, Giusi, et al.
Publicado: (2016)

Amyloid β-peptides 1–40 and 1–42 form oligomers with mixed β-sheets
por: Baldassarre, Maurizio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kit401vu1pl894h7g2tue0vps8